CNTXNasdaq

Context Therapeutics Inc.

Alert me on CNTX

Insider buys, 6 months

Congress trades, 6 months

Signals, 6 months

Six months

After each filing

No purchase or sale on this ticker by a member of Congress or an insider yet.

Filings for CNTX

24 held · newest 524 held · newest 2

Loading the filings.

See all 24 filings for CNTX

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Signal history

No signal for this ticker yet. A signal is written when insider buying here scores one dot or more.

Stakes

Jun 30, 2026 Schedule 13G, amended

MPM BioImpact LLC: 1.4%, 1,299,046 shares

Jun 30, 2026 Schedule 13G, amended

Blue Owl Capital Holdings LP: 3.2%, 2,934,015 shares

Jun 30, 2026 Schedule 13G, amended

Octagon Capital Advisors LP: 3.3%, 3,050,000 shares

Jun 30, 2026 Schedule 13G

BlackRock, Inc.: 6.7%, 6,169,250 shares

Mar 31, 2026 Schedule 13G, amended

Great Point Partners, LLC: 2.4%, 2,238,496 shares

Mar 31, 2026 Schedule 13G, amended

Blue Owl Capital Holdings LP: 5.5%, 5,089,015 shares

Mar 31, 2026 Schedule 13G

Octagon Capital Advisors LP: 5.7%, 5,250,000 shares

Mar 31, 2026 Schedule 13G, amended

Avidity Partners Management LP: 8.7%, 8,302,808 shares

Mar 31, 2026 Schedule 13G, amended

Soleus Capital Master Fund, L.P.: 7.6%, 6,963,141 shares

Dec 31, 2025 Schedule 13G, amended

Great Point Partners, LLC: 5.1%, 4,683,711 shares

Dec 31, 2025 Schedule 13G, amended

MPM BioImpact LLC: 11.6%, 10,679,391 shares

Feb 2, 2026 Schedule 13G

Soleus Capital Master Fund, L.P.: 5.2%, 4,776,398 shares

Sep 30, 2025 Schedule 13G, amended

Avidity Partners Management LP: 9.9%, 9,200,580 shares

Sep 30, 2025 Schedule 13G, amended

Great Point Partners, LLC: 5.2%, 4,683,711 shares

Schedule 13D is filed within 5 business days of crossing 5 percent by an investor who may seek to influence the company. Schedule 13G is filed by a passive holder, and a large institution has up to 45 days after the quarter end.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal

No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters

No lobbying reports on file.